Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Events in Type 2 Diabetes. IJBR 2025, 3 (1), 320-324. https://doi.org/10.70749/ijbr.v3i1.496.